Tourmaline Bio Inc.

NASDAQ: TRML · Real-Time Price · USD
22.50
0.11 (0.49%)
At close: Aug 15, 2025, 3:59 PM
22.13
-1.62%
After-hours: Aug 15, 2025, 05:03 PM EDT

Tourmaline Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
40K 40K 40K 2.28M 2.28M 2.28M 2.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
42K 52K 50K 1.17M 1.17M 1.42M 2.05M 1.46M 2.05M 2.38M 2.23M 1.86M 1.44M 976K 623K 560K 522K 490K
Gross Profit
-2K -12K -10K 1.11M 1.11M 858K 229K -1.46M -2.05M -2.38M -2.23M -1.86M -1.44M -976K -623K -560K -522K -490K
Operating Income
-102.45M -98.45M -89.73M -78.82M -61.02M -55.42M -45.41M -30.52M -23.88M -7.52M -19.7K -14.4M -27.46M -38.5M -47.51M -39.95M -33.03M -26.71M
Interest Income
11.09M 15.58M 16.52M 14.94M 11.73M 7.25M 3.04M 1.05M n/a n/a n/a n/a 116K 116K 116K 116K n/a 74K
Pretax Income
-88.47M -82.87M -73.21M -63.88M -49.29M -47.93M -42.12M -29.23M -23.64M -7.52M -19.7K -14.26M -27.19M -38.53M -47.83M -40.37M -33.85M -27.16M
Net Income
-88.47M -82.87M -73.21M -63.88M -50.72M -49.36M -43.55M -30.65M -23.64M -7.52M -19.7K -14.26M -27.19M -38.53M -47.83M -40.37M -33.85M -27.16M
Selling & General & Admin
22.69M 22.58M 22.75M 9.2M 13.2M 8.89M 4.12M 12.4M 3.29M 1.37M 2.17K 3.61M 7.32M 10.67M 13.07M 11.79M 10.14M 8.02M
Research & Development
79.77M 75.87M 66.98M 61.04M 41.98M 40.7M 35.46M 20.86M 20.6M 6.15M 17.53K 10.6M 19.79M 27.34M 33.81M 27.6M 22.38M 18.21M
Other Expenses
n/a n/a n/a 8.57M 5.83M 6.08M 6.08M -2.49M 245K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
102.46M 98.45M 89.73M 78.81M 61.01M 55.42M 45.41M 30.52M 23.88M 7.52M 19.7K 14.21M 27.1M 38.01M 46.88M 39.39M 32.51M 26.23M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 295K 589K 589K 868K 573K
Selling & Marketing Expenses
10K n/a n/a -10K -10K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
102.48M 98.48M 89.76M 78.82M 61.02M 55.42M 45.41M 30.52M 23.88M 7.52M 19.7K 14.4M 27.46M 38.5M 47.51M 39.95M 33.03M 26.71M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a 1.3M -17.12M -34.62M -52.39M -53.69M -35.27M -17.77M n/a n/a n/a n/a
Shares Outstanding (Basic)
25.75M 25.69M 25.8M 25.77M 25.72M 24.08M 16M 20.34M 12.41M 20.34M 10.88M 10.88M 10.88M 10.88M 4.09M 4.07M 2.74M 3.83M
Shares Outstanding (Diluted)
25.75M 25.69M 25.8M 25.77M 25.72M 24.08M 16M 20.34M 12.41M 20.34M 10.88M 10.88M 10.88M 10.88M 4.09M 4.07M 2.74M 3.83M
EPS (Basic)
-3.43 -3.21 -2.87 -2.82 -2.38 -3 -2.82 -2.01 -1.67 -0.37 -0.00 -3.48 -6.66 -10.81 -13.24 -19.36 -25.58 -28.72
EPS (Diluted)
-3.43 -3.21 -2.87 -2.82 -2.38 -3 -2.82 -2.01 -1.67 -0.37 -0.00 -3.48 -6.66 -10.81 -13.24 -19.36 -25.58 -28.72
EBITDA
-102.47M -98.47M -89.74M -78.78M -62.61M -57.01M -47M 4.83M -5.33M -6.46M -16.74M -67.89M -62.25M -55.67M -46.77M -39.22M -32.46M -26.09M
EBIT
-92.73M -91.61M -86.16M -78.82M -63.76M -58.16M -48.15M 3.69M -6.75M -8.47M -19.23M -56.4M -49.52M -42.48M -33.23M -39.78M -32.98M -26.59M
Depreciation & Amortization
31K 41K 39K 41K 1.16M 1.15M 1.15M 1.14M 14.96K 20.52K 14.79K 202.78K 367.83K 488.26K 623K 560K 522K 490K